Skip to content

Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers

Empathy and (Self-)Compassion to Improve the Quality of Life of Parkinson's Disease Patients and Caregivers: an Exploratory Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07097298
Enrollment
30
Registered
2025-07-31
Start date
2025-11-06
Completion date
2027-07-31
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease(PD)

Keywords

Empathy, (self-)compassion, Parkinson disease (PD)

Brief summary

The goal of this clinical trial is to improve quality of life in Parkinson's Disease (PD) patients by increasing their empathy and their (self-)compassion. The main question it aims to answer is: Does the level of quality of life in PD patients and caregivers improve after empathy/(self-)compassion training? Participants will be delivered a 6-week empathy and compassion training (mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion) and will also be asked to answer questionnaires before and after the training

Interventions

BEHAVIORALempathy and compassion training

A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises

Sponsors

CTU-EOC Clinical Trial Unit Ente Ospedaliero Cantonale
CollaboratorUNKNOWN
Alain Kaelin
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of PD * Hoehn and Yahr scale, stage ≤ 3 * Mini Mental State Examination with a score ≥ 26 * Able to give informed consent as documented by signature * At least, secondary school education * To have a regular caregiver at home

Exclusion criteria

* Any medical condition that is not PD, such as drug induced parkinsonism * Major depression, dysthymia, or according to DSM-V * Other neurological or psychiatric diseases * Neuropsychological scores compatible with the diagnosis of early dementia * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc For CAREGIVERS: Inclusion criteria * Taking care of the patient on a regular basis, i.e., at least 3 days per week * Being caregiver of the patients for at least 3 months * At least, secondary school education * Written informed consent

Design outcomes

Primary

MeasureTime frameDescription
PD patients quality of life improvementfrom baseline to the end of intervention (6weeks)the change (no min / max values foreseen) in the level of quality of life in PD patients as measured by the Parkinson's Disease Questionnaire (PDQ-8), which assesses 8 domains of quality of life: mobility, activities of daily of living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort; higher scores indicate a worse quality of life

Secondary

MeasureTime frameDescription
change in the level of empathy in PD patients and caregiversfrom baseline to the end of intervention (6weeks)change in the level of empathy in PD patients and caregivers as measured by Interpersonal Reactivity Index (IRI): this questionnaire captures both the cognitive and emotional facets of empathy. It includes four seven-item subscales: 1) Fantasy (F) and 2) Perspective Taking (PT) for the cognitive dimension and 3) Empathic Concern (EC) and 4) Personal Distress (PersDis) for an emotional one. The F scale assesses the tendency to identify oneself imaginatively in characters and situations (for example, movie characters and novels); the PT scale contains elements that map to the ability to apply the perspectives of other people from their point of view; the EC scale evaluates feelings of compassion and concern regarding other people; the PersDis measures the personal feelings of anxiety and discomfort that are experienced by observing the negative emotion
self-compassion level change in PD patients and caregiversfrom baseline to the end of intervention (6weeks)change in the level of self-compassion in PD patients and caregivers as measured by Self-Compassion Scale (SCS): this is a 26-item validated questionnaire which measures self-compassion with six subscales: self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification. Past studies used this test with people with Parkinson's . The total self-compassion score is the mean of the six subscale means and ranges from 1 to 5, with a higher score indicating greater self-compassion
compassion level change in PD patients and caregiversfrom baseline to the end of intervention (6weeks)change in the level of compassion in PD patients and caregivers as a derived measure of the SCS: a 26-item validated questionnaire, measures self-compassion with six subscales: self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification. Past studies used this test with people with Parkinson's. The total self-compassion score is the mean of the six subscale means and ranges from 1 to 5, with a higher score indicating greater self-compassion
quality of life level change in caregiversfrom baseline to the end of intervention (6weeks)change in the level of quality of life in caregivers as measured by the Family Caregiver Quality of Life Scale (FAMQOL): it evaluates caregivers' quality of life across multiple dimensions (physical, psychological, and social well-being). The FAMQOL consists of 16 self-reported questions with 5-option Likert responses, ranging from Strongly Disagree to Strongly Agree

Countries

Switzerland

Contacts

Primary ContactAlain Kaelin, Prof. MD PhD
alain.kaelin@eoc.ch+41918117342

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026